nafronyl has been researched along with reserpine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Salim, AS | 2 |
3 other study(ies) available for nafronyl and reserpine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Naftidrofuryl protects the rat against chronic gastric ulceration.
Topics: Animals; Female; Gastric Acid; Gastric Mucosa; Ischemia; Male; Nafronyl; Rats; Rats, Inbred Strains; Regional Blood Flow; Reserpine; Stomach; Stomach Ulcer | 1991 |
Gastric mucosal cytoprotection in the rat by naftidrofuryl oxalate.
Topics: Animals; Anti-Ulcer Agents; Female; Furans; Gastric Acid; Gastric Mucosa; Male; Nafronyl; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Stomach Ulcer | 1990 |